CD19-targeting, 3rd Generation CAR T Cells for Refractory B Cells Malignancy
Clinical trial NCT03068416 · COMPLETED
Trial details
- NCT number
- NCT03068416
- Sponsor
- Uppsala University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-18
- Primary completion
- 2021-08-19
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.